Thomas Feegel

Thomas Feegel, co-founder of Beond Ibogaine, shares insights on the complexities of ibogaine therapy at his facility in Cancun. He addresses safety concerns following a tragic incident in 2022, stressing the importance of thorough patient evaluations and data collection. Feegel critiques conventional addiction treatments and advocates for innovative approaches amidst rising overdose rates. He discusses creating a holistic healing environment and the evolving role of psychedelics in mental health, emphasizing the need for ethical standards in therapy.